Bluejay Diagnostics logo
Bluejay Diagnostics
BJDX | NASDAQ
Chart Builder DCF Calculator
$2.29
-$0.32 (-12.26%)
At close: Nov 16, 2026, 4:00 PM ET
$2.29
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Bluejay Diagnostics Company Profile

Company profile explained

Company Profile

Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Furthermore, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.

Key Executives

Name Position
Indranil Dey Principal Financial, Accounting & Executive Officer, President, Chief Executive Officer and Director
Kevin Vance Chief Commercial Officer
Mark W. Feinberg Chief Medical Advisor

Latest SEC Filings

Date Type Title
Nov 04, 2026 8-K Current Report
Oct 13, 2026 8-K Current Report
Oct 06, 2026 8-K Current Report
Sep 08, 2026 8-K Current Report
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 14, 2026 SC 13G Statement of acquisition of beneficial ownership b...
View All SEC Filings ➞
Bluejay Diagnostics
Bluejay Diagnostics logo
Country United States
IPO Date Nov 10, 2021
Industry Medical - Devices
Sector Healthcare
Employees 6
CEO Indranil Dey

Contact Details

360 Massachusetts Avenue Acton, Massachusetts 01720 United States

Stock Details

Ticker Symbol BJDX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001704287
CUSIP Number 095633707
ISIN Number US0956337077
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.